The Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Science Research Council (EPSRC) and Medical Research Council (MRC) are establishing a £25M UK Regenerative Medicine Platform (UKRMP) to address the technical and scientific challenges associated with translating promising scientific discoveries in this area towards clinical impact.

At its core, the first stage of funding supports interdisciplinary and complementary research hubs that together will provide a world-leading programme to promote the development of regenerative therapies by addressing key translational gaps. With the successful establishment of this Platform, up to £6.5M is now available to support second stage funding for the UKRMP to build on this initial investment in order to address specific human health needs.

KEY DATES

The RC sponsors, in partnership with Arthritis Research UK and the Multiple Sclerosis Society are therefore inviting proposals to establish high quality, collaborative research groupings to address key challenges in translational regenerative medicine focused into particular diseases or physiological/organ systems with therapeutic potential. Up to £6.5M is available to support 4-5 successful bids.

Applications across all health areas are welcome, with the exception of cardiovascular disease. Proposals addressing arthritis and related musculoskeletal conditions/rheumatology and multiple sclerosis are particularly encouraged, reflecting the key partnership with Arthritis Research UK and the MS Society in this call.

For further information on Stage II UK Regenerative Medicine Platform – Disease/Systems focused programmes, please contact Research and Income Generation Support at Research and Enterprise.